Moneycontrol PRO

business

Buy Jubilant Life, target Rs 492: Daljeet Singh Kohli

Daljeet Singh Kohli, Head of Reresearch at India Nivesh Securites recommends buying Jubilant Life Sciences with a target of Rs 492.

first published: Dec 2, 2015 03:10 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347